FDA approves Cialis for enlarged prostate
Cialis, Lilly’s blockbuster erectile dysfunction drug, now can be taken to treat enlarged prostate. FDA approval means men who suffer from both disorders can take one medication.
Cialis, Lilly’s blockbuster erectile dysfunction drug, now can be taken to treat enlarged prostate. FDA approval means men who suffer from both disorders can take one medication.
When Jeanette Sabir-Holloway entered dental school at Indiana University in 1976, she was one of only three black students in a class of 120. She would be the only African-American to graduate with her class four years later.
Drugmaker Eli Lilly and Co. doesn’t plan to buy Pfizer Inc.’s $3.58 billion animal-health business, CEO John Lechleiter said Wednesday.
The Children’s Better Health Institute, a division of The Saturday Evening Post Society Inc., plans to ask the Metropolitan Development Commission to rezone a 23-acre parcel on the city’s northwest side.
The integration of the two not-for-profit hospital systems, approved by Howard Regional's board in late May, is now dead, the two hospitals announced Monday.
Eli Lilly and Co., the world’s biggest maker of psychiatric drugs, is in talks with Mustafa Nevzat Ilac Sanayii AS to sell the Turkish company’s treatments in 26 countries, said Mustafa Nevzat’s CEO.
WellPoint Inc.’s participation in buying a majority stake of the private health insurance exchange operator Bloom Health could help it get back to its roots as a health insurer—and make a bit more money in the process.
Indiana University announced a partnership with the Indianapolis-based IU Health hospital system that will launch four primary care clinics in Bloomington, which can be visited for no extra charge by those enrolled in IU’s health plans.
Federal officials on Friday denied Indiana's request to use a state public health savings account to help cover the half-million people who will become eligible for Medicaid in 2014, saying the request was premature and leaving the state program's future in flux.
The new Indianapolis-based organization was formed by Nursing 2000, Nursing 2000 North and the Indiana Nursing Workforce Development Coalition, all of which focused on generating an adequate supply of well-trained nurses.
Reform-induced changes dominate health care panel of health care experts convened by Indianapolis Business Journal.
Researchers at IU and Cornell say that how the federal government defines "affordable" could leave millions of dependents of low and moderate income workers without reasonably priced insurance.
Hill-Rom Holdings Inc., a medical-equipment company based in Indiana, agreed Tuesday to pay nearly $42 million to settle a government lawsuit. The government had accused the company of knowingly submitting false claims to Medicare from 1999 to 2007.
Indianapolis’ largest independent physician group, American Health Network, doesn’t want to sell to a hospital, but its CEO hopes it can hold on until accountable care kicks in.
Dr. Ed Kowlowitz, owner and medical director of the Center for Pain Management in Indianapolis, recently challenged a regional Medicare reimbursement policy and, surprisingly, won. He spoke with IBJ about the experience, as well how his three-physician practice is growing even while many physician practices are selling to hospitals.
Even though Google Inc. has given up on the business of electronic personal health records, Fort Wayne-based NoMoreClipboard.com is launching a new service it thinks will crack open the market.
At three community health centers, all patients will be asked about their alcohol and drug usage confidentially, as part of an early-intervention approach designed to cut down addictions and reduce hospitalization.
Zotec Partners, a fast-growing physician-billing management company based in Carmel, has acquired a family-owned medical-billing firm with 100 employees based in Florida.
A German researcher disputed the validity of a study that found Byetta and another diabetes drug increase cancer risk.
Dr. Murray Korc, an internationally known pancreatic cancer researcher, comes to the cancer center as the first Myles Brand Professor of Cancer Research. The position is funded through a Lilly Endowment grant.